Homepage > Company > Media > Pharma News > 2017 > Lupin launches Temovate generic

Lupin launches Temovate generic

BALTIMORE — Lupin has launched its Clobetasol Propionate Topical Solution USP, 0.05%.

Clobetasol is the generic equivalent of Fougera Pharmaceuticals’ Temovate (clobetasol propionate) Scalp Application, 0.05%. It is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.

ChemSpider 2D Image | Clobetasol propionate | C25H32ClFO5

Temovate Clobetasol Propionate Scalp Application had an estimated U.S. sales of USD 64.1 million in 2016.

March 7, 2017 | By Brian Berk

Source: http://www.drugstorenews.com/

Read also

FDA halts tests of Sanofi drug, acquired in $3.7B buyout, due to side effects

The Food and Drug Administration has required Sanofi to stop treating some patients in Phase 3 trials of an experimental multiple sclerosis drug and pause enrollment in the studies in an effort to ...

FDA Accepts Aflibercept sBLA for Treatment of Diabetic Retinopathy

If approved, the 16-week dosing regimen could offer certain individuals a potentially longer treatment interval and physicians with greater flexibility to individualize treatment. ...

AstraZeneca Bolsters Blood Cancer Pipeline with $1.27B TeneoTwo Takeover

AstraZeneca is strengthening its oncology pipeline with the acquisition of TeneoTwo, which has an ongoing Phase I trial in relapsed and refractory B-cell non-Hodgkin lymphoma, in a deal valued at u...

FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants